Revive Rx LLC dba Revive Rx Pharmacy

FDA inspection history across 2 sites, 2021 to 2026

4
Form 483s
2
Warning letters

Every document, by year

  • Form 483
  • Warning letter

2021: one Form 483; 2022: one Form 483; 2023: one warning letter; 2025: one warning letter and one Form 483; 2026: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2021–26Four Form 483s and two warning letters, at Houston, Texas and Texas.
  2. 2022The longest 483 on file: 9 observations over 6 pages at Houston, Texas.

Cited most

Across all Revive Rx LLC dba Revive Rx Pharmacy observations on file

  • 21 CFR 211.113
    Control of microbiological contamination
    13
  • FDCA 501(a)(2)(A)
    Insanitary conditions
    7
  • 21 CFR 211.42
    Design and construction features
    4
  • 21 CFR 211.67
    Equipment cleaning and maintenance
    1
  • 21 CFR 211.84
    Testing and approval or rejection of components, drug product containers, and closures
    1

The complete Revive Rx LLC dba Revive Rx Pharmacy file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$505$594

15% off buying them one by one

Sites

Documents

6 on file, newest first
DateDocumentPrice
2026-03-27483 Form 483$99
2025-09-22Warning letter Warning letter$99
2025-02-07483 Form 483$99
2023-06-30Warning letter Warning letter$99
2022-05-04483 Form 483$99
2021-08-06483 Form 483$99

FEI number 3016710945 · most recent document Mar 27, 2026

About Revive Rx LLC dba Revive Rx Pharmacy

How many FDA Form 483s has Revive Rx LLC dba Revive Rx Pharmacy received?

FDA Intel has 4 Form 483s on file for Revive Rx LLC dba Revive Rx Pharmacy; the most recent is dated Mar 27, 2026.

When was Revive Rx LLC dba Revive Rx Pharmacy last inspected by FDA?

The most recent FDA inspection document on file for Revive Rx LLC dba Revive Rx Pharmacy is a Form 483 dated Mar 27, 2026, for the site in Houston, Texas.

What did FDA cite at Revive Rx LLC dba Revive Rx Pharmacy?

The regulations cited most in the observations on file for Revive Rx LLC dba Revive Rx Pharmacy are 21 CFR 211.113 (Control of microbiological contamination), 13 times; FDCA 501(a)(2)(A) (Insanitary conditions), 7 times; 21 CFR 211.42 (Design and construction features), 4 times.

Has Revive Rx LLC dba Revive Rx Pharmacy received an FDA warning letter?

Yes. FDA Intel has 2 FDA warning letters on file for Revive Rx LLC dba Revive Rx Pharmacy; the most recent is dated Sep 22, 2025.